282 related articles for article (PubMed ID: 11160339)
21. Roles of endogenous nitric oxide synthase inhibitors and endothelin-1 for regulating myometrial contractions during gestation in the rat.
Momohara Y; Sakamoto S; Obayashi S; Aso T; Goto M; Azuma H
Mol Hum Reprod; 2004 Jul; 10(7):505-12. PubMed ID: 15155819
[TBL] [Abstract][Full Text] [Related]
22. Time-dependent aggravation or attenuation of lipopolysaccharide-induced gastric injury by nitric oxide synthase inhibition.
Suliburk JW; Helmer KS; Kennison SD; Mercer DW; Robinson EK
J Surg Res; 2005 Dec; 129(2):265-71. PubMed ID: 16026802
[TBL] [Abstract][Full Text] [Related]
23. Role of inducible nitric oxide synthase in leukocyte extravasation in vivo.
Cockrell A; Laroux FS; Jourd'heuil D; Kawachi S; Gray L; Van der Heyde H; Grisham MB
Biochem Biophys Res Commun; 1999 Apr; 257(3):684-6. PubMed ID: 10208844
[TBL] [Abstract][Full Text] [Related]
24. Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthase.
Connor JR; Manning PT; Settle SL; Moore WM; Jerome GM; Webber RK; Tjoeng FS; Currie MG
Eur J Pharmacol; 1995 Jan; 273(1-2):15-24. PubMed ID: 7537678
[TBL] [Abstract][Full Text] [Related]
25. Enhancement of the anti-inflammatory and anti-arthritic effects of theophylline by a low dose of a nitric oxide donor or non-specific nitric oxide synthase inhibitor.
Gomaa A; Elshenawy M; Afifi N; Mohammed E; Thabit R
Br J Pharmacol; 2009 Dec; 158(7):1835-47. PubMed ID: 19888960
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic administration of nitric oxide synthase inhibitors reverses hyperalgesia but not inflammation in a rat model of polyarthritis.
Tedesco LS; Fuseler J; Grisham M; Wolf R; Roerig SC
Pain; 2002 Feb; 95(3):215-223. PubMed ID: 11839421
[TBL] [Abstract][Full Text] [Related]
27. Selective inhibition of inducible nitric oxide synthase in experimental osteoarthritis is associated with reduction in tissue levels of catabolic factors.
Pelletier JP; Lascau-Coman V; Jovanovic D; Fernandes JC; Manning P; Connor JR; Currie MG; Martel-Pelletier J
J Rheumatol; 1999 Sep; 26(9):2002-14. PubMed ID: 10493683
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological characterization of guanidinoethyldisulphide (GED), a novel inhibitor of nitric oxide synthase with selectivity towards the inducible isoform.
Szabó C; Bryk R; Zingarelli B; Southan GJ; Gahman TC; Bhat V; Salzman AL; Wolff DJ
Br J Pharmacol; 1996 Aug; 118(7):1659-68. PubMed ID: 8842429
[TBL] [Abstract][Full Text] [Related]
29. Selective inducible nitric oxide synthase (iNOS) inhibition attenuates remote acute lung injury in a model of ruptured abdominal aortic aneurysm.
Harkin DW; Rubin BB; Romaschin A; Lindsay TF
J Surg Res; 2004 Aug; 120(2):230-41. PubMed ID: 15234218
[TBL] [Abstract][Full Text] [Related]
30. Monophosphoryl lipid A stimulated up-regulation of nitric oxide synthase and nitric oxide release by human monocytes in vitro.
Saha DC; Astiz ME; Lin RY; Rackow EC; Eales LJ
Immunopharmacology; 1997 Oct; 37(2-3):175-84. PubMed ID: 9403336
[TBL] [Abstract][Full Text] [Related]
31. Suppressive effects of a selective inducible nitric oxide synthase (iNOS) inhibitor on pancreatic beta-cell dysfunction.
Kato Y; Miura Y; Yamamoto N; Ozaki N; Oiso Y
Diabetologia; 2003 Sep; 46(9):1228-33. PubMed ID: 12898012
[TBL] [Abstract][Full Text] [Related]
32. Sepsis increases NOS-2 activity and decreases non-NOS-mediated acetylcholine-induced dilation in rat aorta.
Beach PK; Spain DA; Kawabe T; Harris PD; Garrison RN
J Surg Res; 2001 Mar; 96(1):17-22. PubMed ID: 11180991
[TBL] [Abstract][Full Text] [Related]
33. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
[TBL] [Abstract][Full Text] [Related]
34. Selective pharmacological inhibition of distinct nitric oxide synthase isoforms.
Southan GJ; Szabó C
Biochem Pharmacol; 1996 Feb; 51(4):383-94. PubMed ID: 8619882
[TBL] [Abstract][Full Text] [Related]
35. Effects of a nitric oxide donor and nitric oxide synthase inhibitors on luteinizing hormone-induced ovulation in the ex-vivo perfused rat ovary.
Mitsube K; Mikuni M; Matousek M; Brännström M
Hum Reprod; 1999 Oct; 14(10):2537-43. PubMed ID: 10527984
[TBL] [Abstract][Full Text] [Related]
36. Modulation of IL-1-induced cartilage injury by NO synthase inhibitors: a comparative study with rat chondrocytes and cartilage entities.
Cipolletta C; Jouzeau JY; Gegout-Pottie P; Presle N; Bordji K; Netter P; Terlain B
Br J Pharmacol; 1998 Aug; 124(8):1719-27. PubMed ID: 9756389
[TBL] [Abstract][Full Text] [Related]
37. 2-Amino-4-methylpyridine as a potent inhibitor of inducible NO synthase activity in vitro and in vivo.
Faraci WS; Nagel AA; Verdries KA; Vincent LA; Xu H; Nichols LE; Labasi JM; Salter ED; Pettipher ER
Br J Pharmacol; 1996 Nov; 119(6):1101-8. PubMed ID: 8937711
[TBL] [Abstract][Full Text] [Related]
38. Influence of dipyridamole and its combination with NO donor or NO synthase inhibitor on adjuvant arthritis.
Gomaa A; Elshenawy M; Afifi N; Mohammed E; Thabit R
Int Immunopharmacol; 2010 Nov; 10(11):1406-14. PubMed ID: 20800711
[TBL] [Abstract][Full Text] [Related]
39. Inducible nitric oxide synthase inhibitors reduce urinary markers of systemic oxidant stress in murine proliferative lupus nephritis.
Njoku CJ; Patrick KS; Ruiz P; Oates JC
J Investig Med; 2005 Nov; 53(7):347-52. PubMed ID: 16297360
[TBL] [Abstract][Full Text] [Related]
40. Rat myometrial smooth muscle cells express endothelial nitric oxide synthase.
Gangula PR; Dong YL; Yallampalli C
Hum Reprod; 1997 Mar; 12(3):561-8. PubMed ID: 9130760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]